ODYS.NASDAQOdysightai INC

Form 4: Odysight.ai CBO Sagi Eilam Granted 60,000 Stock Options

Sentiment:

Insider Transaction Report


Odysight.ai Inc.'s Chief Business Officer, Sagi Eilam, was granted 60,000 options to purchase common stock with an exercise price of $4.70.

Summary

  • Sagi Eilam, Chief Business Officer of Odysight.ai Inc. (ODYS), was granted 60,000 options to purchase common stock.
  • The options have an exercise price of $4.70 per share.
  • The earliest transaction date for this grant was January 25, 2026.
  • The options will vest and become exercisable as to one-third of the total shares on November 15, 2026.
  • The remaining options will vest in equal quarterly installments over the subsequent 24 months, leading to full vesting on November 15, 2028.
  • The options have an expiration date of January 25, 2033.
  • Following this transaction, Sagi Eilam beneficially owns 60,000 derivative securities directly.

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation event (stock option grant), which is generally viewed as neutral to slightly positive as it aligns management's interests with shareholder value.

Positives

  • The grant of stock options to the Chief Business Officer aligns management's interests with shareholder value creation.
  • This compensation structure can incentivize long-term performance and retention of key executives.

Future Outlook

The options are subject to a vesting schedule, with one-third vesting on November 15, 2026, and full vesting by November 15, 2028, indicating a long-term incentive structure for the executive.

Industry Context

The grant of stock options is a common practice in the technology and publicly traded company sectors to compensate executives, align their interests with shareholders, and incentivize long-term performance and retention.

Comparison to Industry Standards

  • Granting stock options as part of executive compensation is a standard practice across various industries, including technology and AI, to attract and retain talent.
  • The vesting schedule, typically over several years, is also a common mechanism to ensure long-term commitment and performance alignment, comparable to practices at companies like NVIDIA or Microsoft for their key personnel.

Stakeholder Impact

  • Shareholders: The option grant aligns the Chief Business Officer's financial interests with the company's stock performance, potentially leading to increased efforts to enhance shareholder value.
  • Employees: This type of executive compensation can signal stability in leadership and a commitment to long-term growth, which may positively influence employee morale.

Next Steps

  • The options will vest according to the specified schedule, with the first tranche on November 15, 2026.
  • The Chief Business Officer may choose to exercise the vested options at any time before their expiration on January 25, 2033.

Key Dates

DateDescription
01/25/2026Date of earliest transaction (grant date of options)
01/27/2026Signature date of reporting person (filing date)
11/15/2026First vesting date for one-third of the total options
11/15/2028Full vesting date for all options
01/25/2033Expiration date of the options

Recommendation

hold

This Form 4 reports a routine stock option grant to a key executive, which is a standard compensation practice. It does not provide new financial performance data or strategic shifts that would warrant a change in investment recommendation based solely on this filing. Investors should consider this as a normal course of business for executive incentives.

Keywords

Odysight.ai, ODYS, stock options, executive compensation, insider transaction, Form 4, Sagi Eilam, Chief Business Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.